Optimization of complex interventions and a cluster randomizad controlled trial for Vitiligo patients with astringent myxoid syndrome in Uyghur medicine

Hospital of Xinjiang Traditional Uyghur Medicine0 个研究点开始时间: 待定最近更新: 2023年8月21日

适应症

试验速览

暂无简介。

•1) Patients diagnosed as vitiligo in advanced stage, and with VIDA score>1 point.
•2) Patients whose severity rating is Grade 1 (mild, unlimited in special parts, and = 0.09% in other parts (3 knuckles)); Level 2 (moderate, with a white spot area of 1% -5% of the body surface area); Level 3 (moderate to severe, with a white spot area of 6% -50%); Patients with grade 4 (severe, with a white spot area greater than 50%).
•3) Vitiligo patients diagnosed as non-segmental (ordinary) Vitiligo, including sporadic, generalized and mixed vitiligo.
•4) Vitiligo patients with astringent myxoid syndrome in Uyghur medicine.
•5) aged 18-65
•6) with imformed consent.

•1) Patients with Vitiligo of external genitalia, anus and mucous membrane in special parts.
•2) Some skin rashes have left behind Depigmentation, anemic nevus, albinism, and other syndromes that cause leukoplakia, senile leukoplakia, amelanotic nevus, and solar leukoplakia.
•3) Patients with active tuberculosis, malignant tumor progression, or a history of tumor within 5 years.
•4) Combined with severe cardiac insufficiency, severe primary diseases such as liver and kidney systems. (Note: ALT and AST exceed the upper limit of the normal range by 2 times, while Cr exceeds the upper limit of the normal range.)
•5) I have taken steroids and any kind of medicine for Vitiligo in recent 2 weeks; And/or took retinoic acid drugs or steroid preparations for external use and any Topical medication for the treatment of Vitiligo within one week.
•6) Plan for pregnant, pregnant, or lactating women.
•7) Suspected or confirmed history of alcohol or drug abuse.
•8) Allergic constitution (to 2 or more other drugs), or allergic to the drug components in this diagnosis and treatment plan.
•9) Other situations that reduce the likelihood of enrollment or complicate enrollment, such as frequent changes in the work environment, mental disorders, communication difficulties, etc., are deemed unsuitable by researchers to participate in this clinical trial.
•10) participated in clinical trials of other drugs or are currently participating in other clinical trials within the past month.

发起方

Hospital of Xinjiang Traditional Uyghur Medicine